Single dose pharmacokinetics of oral artemether in healthy Malaysian volunteers.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  1997-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1365-2125.1997.00573.XPMID 9146847PMCID PMC2042754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of artemether and dihydroartemisinin in blood plasma by high-performance liquid chromatography for application in clinical pharmacological studies.

  1995cited by this paper
• Measurement of artemisinin and its derivatives in biological fluids.

  1994cited by this paper
• The pharmacokinetics of a single dose of artemisinin in healthy Vietnamese subjects.

  1994cited by this paper
• Artemisinin: current status.

  1994cited by this paper
• Pharmacokinetics of artemether after oral administration to healthy Thai males and patients with acute, uncomplicated falciparum malaria.

  1994cited by this paper
• Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report.

  1991cited by this paper
• The pharmacokinetics of artemisinin after oral, intramuscular and rectal administration to volunteers

  1990cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China

  1985cited by this paper
• Qinghaosu (artemisinin): an antimalarial drug from China.

  1985cited by this paper

• β-Artemether and Lumefantrine Dual Drug Loaded Lipid Nanoparticles: Physicochemical Characterization, Pharmacokinetic Evaluation and Biodistribution Study.

  2022cites this paper
• Antischistosomal and Immune Enhancing Potential of Azadirachta Indica and Ekebergia Capensis in Mice Infected with Schistosoma Mansoni

  2017cites this paper
• Erratum to: A High-Resolution LC–MS/MS Method for the Quantitative Determination of Artemether and Its Metabolite Dihydroartemisinin in Human Plasma and Its Application to Pharmacokinetic Studies

  2016cites this paper
• Pharmacokinetics of a Novel Sublingual Spray Formulation of the Antimalarial Drug Artemether in Healthy Adults

  2015cites this paper
• Efficacité de l'Artésunate-Amodiaquine en chimio-prévention du paludisme saisonnier en milieu scolaire périurbain de Bamako, à Sirakoro-Meguetana, Mali

  2015cites this paper
• Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications

  2014cites this paper
• Artemisinin: An Evolving Antimalarial-Part One

  2013cites this paper
• Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women

  2013cites this paper
• In vitro evaluation of the cytotoxic and genotoxic effects of artemether, an antimalarial drug, in a gastric cancer cell line (PG100)

  2013influential citation
• Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.

  2013cites this paper
• Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether–Lumefantrine in Healthy Volunteers

  2012cites this paper
• Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults

  2012cites this paper
• Discovery of Antimalarial Drug Artemisinin and Beyond

  2012cites this paper
• Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Antimalarial Artemether

  2011cites this paper
• Functional Characterization of CYP2B6 Allelic Variants in Demethylation of Anti-Malarial Artemether

  2011cites this paper
• Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine

  2010cites this paper
• Population Pharmacokinetics and Pharmacodynamics of Artemether and Lumefantrine during Combination Treatment in Children with Uncomplicated Falciparum Malaria in Tanzania

  2010cites this paper
• Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy

  2009cites this paper
• Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.

  2009cites this paper
• First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone

  2008cites this paper
• In vitro interaction of dihydroartemisin and lumefantrine in clinical field isolates from Bangladesh

  2007cites this paper
• Quantitative Analysis of Artemether and its Metabolite Dihydroartemisinin in Human Plasma by LC with Tandem Mass Spectrometry

  2006cites this paper
• Anti-malaria drug treatment in Vietnam

  2004cites this paper
• Comparative Pharmacokinetics of Intramuscular Artesunate and Artemether in Patients with Severe Falciparum Malaria

  2004cites this paper
• Combination Chemotherapy of Schistosomiasis in Laboratory Studies and Clinical Trials

  2003cites this paper
• The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro.

  2001cites this paper
• A comparison of oral artesunate and artemether antimalarial bioactivities in acute falciparum malaria.

  2001cites this paper
• Pharmacokinetics of Artemisinin-Type Compounds

  2000cites this paper
• Absence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials

  2000cites this paper
• Malaria: Basic Biology and Options for Therapy and Prophylaxis

  2000cites this paper
• Clinical Pharmacokinetics of Artemether and Lumefantrine (Riamet®)

  1999cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine

  1999cites this paper
• Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication.

  1999cites this paper
• Synergism of benflumetol and artemether in Plasmodium falciparum.

  1999cites this paper
• Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.

  1999cites this paper
• Simultaneous determination of artemether and its major metabolite dihydroartemisinin in plasma by gas chromatography-mass spectrometry-selected ion monitoring.

  1999cites this paper
• Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria.

  1999cites this paper
• Antiparasitaires

  1998cites this paper
• The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects

  1998cites this paper
• Comparative pharmacokinetic study of oral and rectal formulations of artesunic acid in healthy volunteers

  1998cites this paper
• In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine

  1998cites this paper
• Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.

  1998cites this paper